Ventyx Biosciences, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2020 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Ventyx Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2024.
  • Ventyx Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $5.17M, a 15.9% decline year-over-year.
  • Ventyx Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $22.9M, a 19.8% decline year-over-year.
  • Ventyx Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $22.9M, a 19.8% decline from 2023.
  • Ventyx Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $28.6M, a 72.5% increase from 2022.
  • Ventyx Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $16.6M, a 507% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $22.9M -$5.66M -19.8% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 $28.6M +$12M +72.5% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 $16.6M +$13.8M +507% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $2.73M +$2.69M +5967% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $45K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.